Indication context: Semaglutide injection is FDA-approved under brand names Ozempic (type 2 diabetes, CV risk reduction) and Wegovy (chronic weight management, obesity or overweight with 1 weight-related comorbidity)
Inform patients that management requires implementing a long-term plan, setting realistic weight goals, and overcoming ongoing challenges of weight maintenance
How This Works Ipamorelin binds to the growth hormone secretagogue receptor (GHSR-1a) and stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner [1] [2]
An efficient biological system (or a well-formulated supplement) uses the enzyme glutathione reductase to convert GSSG back into GSH, creating a continuous cycle of protection that maintains a healthy redox balance
Step-therapy exceptions are available for documented contraindications or prior failures
These properties position them as a potential tool in managing SLD